Open-labeled Pilot Study on the Efficacy of a New Food Supplement Composed of Natural Stem Cell Mobilizers for the Improvement of Motor Performance and Quality of Life in Parkinsonian Patients

Status: Recruiting
Location: See location...
Intervention Type: Dietary supplement
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY

Parkinson's disease is defined as the progressive loss or deterioration of dopaminergic neurons, Treatment approaches to maintain the normal dopamine level that include medication, surgery, cell therapy supplementation of L-Dihydroxyphenylalanine (L-Dopa), a precursor of dopamina, Stem cells from bone marrow can be mobilized according to the need of repair of the tissue. Suggested use of the food supplement actually sold in the USA and in Europe: Take two capsules, 1 to 3 times per day with a glass of water. Increase the Stem Cell circulating in the peripheral blood.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 21
Maximum Age: 90
Healthy Volunteers: f
View:

• Adults from both genders

• Diagnosed by neurologist or qualified health care practitioner with PD for 5 years or more

• Stabilized symptomatic treatment for PD for more than 3 months

• Age: over 21 years old

• Volunteers able to understand the nature of the study and to sign a written consent form

Locations
Other Locations
Spain
Clinica Castello 68
RECRUITING
Madrid
Contact Information
Primary
Miguel G Garber, MD
mggarber@gmail.com
34 628766753
Backup
Felix Pedrero, MD
consulta@doctorpedrero.com
34 622411766
Time Frame
Start Date: 2023-01-05
Estimated Completion Date: 2025-10-15
Participants
Target number of participants: 40
Treatments
Experimental: Experimental Stemregen
Experimental product encapsulated will be consumed orally with a glass of water. Six capsules per day will be consumed daily for 6 months.
Related Therapeutic Areas
Sponsors
Leads: Sociedad Española de Medicina Regenerativa y Terapia Celular

This content was sourced from clinicaltrials.gov